CSPCY (CSPCY) Stock Price & Analysis
CSPCY (CSPCY) fell 1.10% to USD 3.6 as of June 9, 2026 at 23:51 UTC, according to Nexqual real-time market data.
CSPCY last closed at USD 3.64; the session ranged USD 3.53–3.6 on volume of 15 shares. Market capitalization is $10.26B, with a 52-week range of USD 3.45–5.83 (PNK). Source: Nexqual, June 9, 2026 at 23:51 UTC.
Key Statistics (as of June 9, 2026 at 23:51 UTC)
| Price | USD 3.6 |
|---|---|
| Change | ▼ 1.10% (down) |
| Previous Close | USD 3.64 |
| Open | USD 3.53 |
| Day Range | USD 3.53 – 3.6 |
| 52-Week Range | USD 3.45 – 5.83 |
| Volume | 15 shares |
| Market Cap | $10.26B |
| Exchange | PNK |
Technical Analysis (CSPCY)
Nexqual's technical model rates CSPCY "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 39.14 (neutral) |
| vs SMA50 | Below (USD 4.24) |
| MACD | -0.16 (negative) |
Analyst Ratings (CSPCY)
Wall Street analysts rate CSPCY "None", per Nexqual as of June 9, 2026 at 23:51 UTC.
| Consensus Rating | None |
|---|
Earnings (CSPCY)
| Revenue Estimate | $8.96B |
|---|
Source: Nexqual, June 9, 2026 at 23:51 UTC.
Financials & Fundamentals (CSPCY)
| Total Revenue | $25.46B |
|---|---|
| Revenue Growth (YoY) | -7.80% |
| Gross Margin | +65.29% |
| Operating Margin | +15.06% |
| Profit Margin | +12.82% |
| ROE | +9.56% |
| Debt / Equity | 1.86 |
| Total Cash | $10.37B |
| Total Debt | $641.11M |
Source: Nexqual, June 9, 2026 at 23:51 UTC.
Financial Health Score (CSPCY)
Nexqual rates CSPCY's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:51 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 65%, operating 15% |
| Balance Sheet | Strong — $10.4B cash vs $641M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — ROE 10% |
Ownership (CSPCY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.85B |
| Float | 1.91B |
Source: Nexqual, June 9, 2026 at 23:51 UTC.
Leadership (CSPCY)
CSPCY is led by Lei Cai (age 45), CEO & Vice Chairman of the Board, per Nexqual as of June 9, 2026 at 23:51 UTC.
| CEO & Vice Chairman of the Board | Lei Cai (age 45) |
|---|---|
| Executive Chairman | Dongchen Cai (age 71) |
| COO & Vice-Chairman of the Board | Qingjie Wei (age 55) |
| Executive Director & Chief Scientist | Chunlei Li (age 49) |
| Executive Director | Huaiyu Wang (age 62) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
| MTHRY | M3, Inc. | USD 5.01 | ▲ 3.32% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| RCRUY | Recruit Holdings Co., Ltd. | USD 13.85 | ▲ 7.45% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:51 UTC. This page is informational and not investment advice.